BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ren YX, Xu GM, Li ZS, Song YG. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases. World J Gastroenterol 2004; 10(6): 881-884 [PMID: 15040037 DOI: 10.3748/wjg.v10.i6.881]
URL: https://www.wjgnet.com/1007-9327/full/v10/i6/881.htm
Number Citing Articles
1
H. Oettle, A. Goerke, A. Kaiser, V. Budach, P. Vogel. Therapiekonzepte Onkologie. 2007;  doi: 10.1007/978-3-540-28978-4_34
2
Craig D. Logsdon, Baoan Ji. Ras Activity in Acinar Cells Links Chronic Pancreatitis and Pancreatic Cancer. Clinical Gastroenterology and Hepatology 2009; 7(11) doi: 10.1016/j.cgh.2009.07.040
3
Guo Zihao, Zhang Jie, Liang Yan, Zhang Jing, Chen Jing, Li Xue, Zhu Jing, Li Wing Heng, Gao Ru, Hao Jianyu. Analyzing S100A6 Expression in Endoscopic Ultrasonography-guided Fine-needle Aspiration Specimens. Journal of Clinical Gastroenterology 2013; 47(1) doi: 10.1097/MCG.0b013e3182601752
4
Altaf Mohammed, Li Qian, Naveena B. Janakiram, Stan Lightfoot, Vernon E. Steele, Chinthalapally V. Rao. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL‐KrasG12D/+ mice. International Journal of Cancer 2012; 131(8) doi: 10.1002/ijc.27456
5
Nisa Kubiliun, Afonso Ribeiro, Yao-Shan Fan, Caio Max Rocha-Lima, Danny Sleeman, Jaime Merchan, Jamie Barkin, Joe Levi. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results. Gastrointestinal Endoscopy 2011; 74(3) doi: 10.1016/j.gie.2011.04.043
6
Heike Immervoll, Dag Hoem, Kalaiarasy Kugarajh, Solrun J. Steine, Anders Molven. Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes. Virchows Archiv 2006; 448(6) doi: 10.1007/s00428-006-0191-8
7
Altaf Mohammed, Naveena B. Janakiram, Misty Brewer, Ashley Duff, Stan Lightfoot, Richard S. Brush, Robert E. Anderson, Chinthalapally V. Rao. Endogenous n-3 Polyunsaturated Fatty Acids Delay Progression of Pancreatic Ductal Adenocarcinoma in Fat-1-p48Cre/+-LSL-KrasG12D/+ Mice. Neoplasia 2012; 14(12) doi: 10.1593/neo.121508
8
Gunnar Folprecht, Michael Geißler, Diana Lüftner, Helmut Öttle, Kurt Possinger, Anne C. Regierer. Facharzt Hämatologie Onkologie. 2007;  doi: 10.1016/B978-343723770-6.50021-1
9
Marcus Bahra, Florian Lordick, Manfred P. Lutz, Matthias Glanemann, Peter Neuhaus. Viszeralmedizin. 2015;  doi: 10.1007/978-3-642-14301-4_38
10
Altaf Mohammed, Naveena Janakiram, Shubham Pant, Chinthalapally Rao. Molecular Targeted Intervention for Pancreatic Cancer. Cancers 2015; 7(3) doi: 10.3390/cancers7030850
11
Mansi A. Parasramka, Shadan Ali, Sanjeev Banerjee, Tara Deryavoush, Fazlul H Sarkar, SmitiV. Gupta. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures. Molecular Nutrition & Food Research 2013; 57(2) doi: 10.1002/mnfr.201200297
12
Marta Crous-Bou, Miquel Porta, Eva Morales, Tomàs López, Alfredo Carrato, Elisa Puigdomènech, Francisco X. Real. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study. Cancer Causes & Control 2009; 20(5) doi: 10.1007/s10552-008-9267-x
13
Chinthalapally V. Rao, Altaf Mohammed, Naveena B. Janakiram, Qian Li, Rebekah L. Ritchie, Stan Lightfoot, Awasthi Vibhudutta, Vernon E. Steele. Inhibition of Pancreatic Intraepithelial Neoplasia Progression to Carcinoma by Nitric Oxide-Releasing Aspirin in p48Cre/+-LSL-KrasG12D/+ Mice. Neoplasia 2012; 14(9) doi: 10.1593/neo.121026
14
William R. Brugge. Optimizing Methods for the Diagnosis of Pancreatic Cancer. Journal of Clinical Gastroenterology 2007; 41(10) doi: 10.1097/MCG.0b013e318146849f
15
Ho-Jae Lee, Young-Min Han, Jeong Min An, Eun A. Kang, Yong Jin Park, Ji-Young Cha, Ki Baik Hahm. Role of omega-3 polyunsaturated fatty acids in preventing gastrointestinal cancers: current status and future perspectives. Expert Review of Anticancer Therapy 2018; 18(12) doi: 10.1080/14737140.2018.1524299
16
Facharzt Hämatologie Onkologie. 2012;  doi: 10.1016/B978-3-437-21212-3.10048-7
17
Craig D. Logsdon, Baoan Ji, Rosa F. Hwang. Pancreatic Cancer. 2010;  doi: 10.1007/978-0-387-77498-5_11
18
Xiang-Lin Tan, Kalyan K. Bhattacharyya, Shamit K. Dutta, William R. Bamlet, Kari G. Rabe, Enfeng Wang, Thomas C. Smyrk, Ann L. Oberg, Gloria M. Petersen, Debabrata Mukhopadhyay. Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling. Pancreas 2015; 44(4) doi: 10.1097/MPA.0000000000000308
19
Talha Bader, Abdelsalam Ismail. Higher prevalence of KRAS mutations in colorectal cancer in Saudi Arabia: Propensity for lung metastasis. Alexandria Journal of Medicine 2014; 50(3) doi: 10.1016/j.ajme.2014.01.003